Search Results - "Khan, Md Abdul Hye"
-
1
Fructose Stimulates Na/H Exchange Activity and Sensitizes the Proximal Tubule to Angiotensin II
Published in Hypertension (Dallas, Tex. 1979) (01-03-2014)“…The proximal nephron reabsorbs 60% to 70% of the fluid and sodium and most of the filtered bicarbonate via Na/H exchanger 3. Enhanced proximal nephron…”
Get full text
Journal Article -
2
Orally Active Epoxyeicosatrienoic Acid Analog Attenuates Kidney Injury in Hypertensive Dahl Salt–Sensitive Rat
Published in Hypertension (Dallas, Tex. 1979) (01-11-2013)“…Salt-sensitive hypertension leads to kidney injury. The Dahl salt–sensitive hypertensive rat (Dahl SS) is a model of salt-sensitive hypertension and…”
Get full text
Journal Article -
3
Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats
Published in Clinical science (1979) (30-04-2019)“…Epoxyeicosatrienoic acids (EETs) and their synthetic analogs have cardiovascular protective effects. Here, we investigated the action of a novel EET analog…”
Get more information
Journal Article -
4
Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition
Published in Clinical science (1979) (01-10-2014)“…Epoxyeicosatrienoic acids (EETs) contribute to haemodynamics, electrolyte homoeostasis and blood pressure regulation, leading to the concept that EETs can be…”
Get more information
Journal Article -
5
Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition
Published in Frontiers in pharmacology (30-06-2017)“…Renal fibrosis, which is a critical pathophysiological event in chronic kidney diseases, is associated with renal epithelial-to-mesenchymal transition (EMT)…”
Get full text
Journal Article -
6
Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice
Published in Frontiers in pharmacology (10-05-2019)“…Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disorder that causes life threatening renal disease and current therapies are limited…”
Get full text
Journal Article -
7
Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis
Published in International journal of molecular sciences (18-05-2016)“…Cytochrome P450 (CYP) monooxygenases epoxidize the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid into novel epoxydocosapentaenoic acids (EDPs)…”
Get full text
Journal Article -
8
Azilsartan Decreases Renal and Cardiovascular Injury in the Spontaneously Hypertensive Obese Rat
Published in Cardiovascular drugs and therapy (01-08-2014)“…Purpose Angiotensin II type 1 receptor blockers (ARBs) are widely used in treating hypertension. In the present study, we tested the hypothesis that a novel…”
Get full text
Journal Article -
9
Azilsartan Improves Glycemic Status and Reduces Kidney Damage in Zucker Diabetic Fatty Rats
Published in American journal of hypertension (01-08-2014)“…BACKGROUND Azilsartan medoxomil (AZL-M), an angiotensin II receptor blocker, demonstrates antihypertensive and organ protective effects in hypertension. We…”
Get full text
Journal Article -
10
Radiation-induced afferent arteriolar endothelial-dependent dysfunction involves decreased epoxygenase metabolites
Published in American journal of physiology. Heart and circulatory physiology (01-06-2016)“…Chronic kidney disease is a known complication of hematopoietic stem cell transplant (HSCT) and can be caused by irradiation at the time of the HSCT. In our…”
Get more information
Journal Article -
11
Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
Published in Frontiers in pharmacology (23-09-2014)“…Epoxyeicosatrienoic acids (EETs) contribute to blood pressure regulation leading to the concept that EETs can be therapeutically targeted for hypertension and…”
Get full text
Journal Article -
12
A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice
Published in Biochemical pharmacology (01-08-2019)“…[Display omitted] Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are the most prevalent metabolic liver disorders and a…”
Get full text
Journal Article -
13
A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes
Published in Diabetologia (01-10-2018)“…Aims/hypothesis The metabolic syndrome is a cluster of risk correlates that can progress to type 2 diabetes. The present study aims to evaluate a novel…”
Get full text
Journal Article -
14
Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats
Published in British journal of pharmacology (01-11-2021)“…Background and Purpose Diabetic nephropathy is a common complications related to high morbidity and mortality in type 2 diabetes. We investigated the action of…”
Get full text
Journal Article -
15
The contribution of α1B-adrenoceptor subtype in the renal vasculature of fructose-fed Sprague–Dawley rats
Published in European journal of nutrition (01-06-2011)“…Purpose Fructose feeding induces a moderate increase in blood pressure, insulin resistance, and hyperinsulinemia. This study investigated the role of α 1B…”
Get full text
Journal Article -
16
Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis
Published in Frontiers in immunology (03-01-2024)“…Renal fibrosis associated with inflammation is a critical pathophysiological event in chronic kidney disease (CKD). We have developed DM509 which acts…”
Get full text
Journal Article -
17
Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3
Published in American journal of physiology. Heart and circulatory physiology (01-11-2018)“…Epoxyeicosatrienoic acids (EETs) decrease cardiac ischemia-reperfusion injury; however, the mechanism of their protective effect remains elusive. Here, we…”
Get more information
Journal Article -
18
Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity
Published in International journal of molecular sciences (10-03-2021)“…Although epoxyeicosatrienoic acid (EET) analogs have performed well in several acute and chronic kidney disease models, targeted delivery of EET analogs to the…”
Get full text
Journal Article -
19
Dual soluble epoxide hydrolase inhibitor/PPAR-γ agonist attenuates renal fibrosis
Published in Prostaglandins & other lipid mediators (01-10-2020)“…•Renal fibrosis is the most common pathophysiological event in chronic kidney disease (CKD) and is an independent predictor of long-term CKD prognosis.•A novel…”
Get full text
Journal Article -
20
A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat
Published in Prostaglandins & other lipid mediators (01-09-2016)“…•We investigated effects of a novel dual acting molecule that concurrently inhibits two arachidonic acid metabolizing enzymes (cyclooxygenase-2 and soluble…”
Get full text
Journal Article